FDA Inspection 1202361 — Gundersen Clinic Ltd, IRB #1
The FDA completed an inspection of Gundersen Clinic Ltd, IRB #1 on April 6, 2023 in La Crosse, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- La Crosse, WI (United States)
Additional Details
IRB